Labshake search

1 - 6 of 6 citations for Cyanine5 NHS ester minimaldye since 2020

• Outer surface lipoproteins from the Lyme disease spirochete exploit the molecular switch mechanism of the complement protease C1s

  Ryan J. Garrigues, et al., bioRxiv - Biochemistry 2022

  Quote: ... or 20% NHS (AP; Innovative Research) and addition of 2 μM Elp proteins in either CP/LP buffer (10 mM HEPES (pH 7.3) ...
• Outer surface lipoproteins from the Lyme disease spirochete exploit the molecular switch mechanism of the complement protease C1s

  Ryan J. Garrigues, et al., bioRxiv - Biochemistry 2022

  Quote: ... and 2% normal human serum (NHS; Innovative Research) in GHB++ (10 mM HEPES (pH 7.3) ...
• Outer surface lipoproteins from the Lyme disease spirochete exploit the molecular switch mechanism of the complement protease C1s

  Ryan J. Garrigues, et al., bioRxiv - Biochemistry 2022

  Quote: ... Reactions proceeded with 2% normal human serum (NHS) (CP; Innovative Research), 2% C1q-depleted serum (LP ...
• Post-translational modification by the Pgf glycosylation machinery modulates Streptococcus mutans physiology and virulence

  Nicholas de Mojana di Cologna, et al., bioRxiv - Microbiology 2022

  Quote: ... Pooled normal human complement serum (NHS; a source of complement) (Innovative Research) or heat-inactivated NHS (HIS ...
• “Conformational dynamics of C1r inhibitor proteins from Lyme disease and relapsing fever spirochetes”

  Sourav Roy, et al., bioRxiv - Microbiology 2023

  Quote: ... or FbpC-C H252A were serially diluted (two-fold dilution range: 1,000 nM to 0.5 nM) and incubated with 2% normal human serum (NHS) (Innovative Research) for CP-specific ELISAs ...
• A structural basis for inhibition of the complement initiator protease C1r by Lyme disease spirochetes

  Ryan J. Garrigues, et al., bioRxiv - Microbiology 2021

  Quote: ... were coated with human IgM (MP Biomedical) and activation of classical pathway was monitored using 2% normal human serum (NHS; Innovative Research) and C4b detection was determined by monoclonal antibody (Santa Cruz Biotechnology) ...